Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 331

1.

Metabolic syndrome is not associated with markers of subclinical atherosclerosis, serum adiponectin and endogenous androgen concentrations in Japanese men with Type 2 diabetes.

Fukui M, Ose H, Kitagawa Y, Kamiuchi K, Nakayama I, Ohta M, Obayashi H, Yamasaki M, Hasegawa G, Yoshikawa T, Nakamura N.

Diabet Med. 2007 Aug;24(8):864-71. Epub 2007 Jun 25.

PMID:
17593243
2.

Relationship between low serum endogenous androgen concentrations and arterial stiffness in men with type 2 diabetes mellitus.

Fukui M, Ose H, Kitagawa Y, Yamazaki M, Hasegawa G, Yoshikawa T, Nakamura N.

Metabolism. 2007 Sep;56(9):1167-73.

PMID:
17697857
3.

Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness.

Kawamoto R, Tomita H, Ohtsuka N, Inoue A, Kamitani A.

J Atheroscler Thromb. 2007 Apr;14(2):78-85.

5.

Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus.

Fukui M, Tanaka M, Shiraishi E, Harusato I, Hosoda H, Asano M, Kadono M, Hasegawa G, Yoshikawa T, Nakamura N.

Metabolism. 2008 May;57(5):625-9. doi: 10.1016/j.metabol.2007.12.005.

PMID:
18442624
6.

Impact of waist circumference versus adiponectin level on subclinical atherosclerosis: a cross-sectional analysis in a sample from the general population.

Holewijn S, den Heijer M, van Tits LJ, Swinkels DW, Stalenhoef AF, de Graaf J.

J Intern Med. 2010 Jun;267(6):588-98. doi: 10.1111/j.1365-2796.2009.02192.x. Epub 2009 Nov 4.

7.

Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.

Nakamura A, Shikata K, Hiramatsu M, Nakatou T, Kitamura T, Wada J, Itoshima T, Makino H.

Diabetes Care. 2005 Dec;28(12):2890-5.

PMID:
16306550
8.

Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.

Onat A, Hergenç G, Can G, Küçükdurmaz Z.

Obesity (Silver Spring). 2009 Mar;17(3):564-70. doi: 10.1038/oby.2008.564. Epub 2008 Dec 18.

9.

Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients.

Yun JE, Sull JW, Lee HY, Park E, Kim S, Jo J, Lee SJ, Kim SY, Choi YJ, Jee SH, Huh KB.

Diabetes Metab Res Rev. 2009 Mar;25(3):259-65. doi: 10.1002/dmrr.946.

PMID:
19214966
10.

Impact of the metabolic syndrome and its components combinations on arterial stiffness in Type 2 diabetic men.

Levisianou D, Melidonis A, Adamopoulou E, Skopelitis E, Koutsovasilis A, Protopsaltis I, Zairis M, Kougialis S, Skoularigis I, Koukoulis G, Foussas S, Triposkiadis F.

Int Angiol. 2009 Dec;28(6):490-5.

PMID:
20087288
11.

Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.

Bianchi C, Penno G, Malloggi L, Barontini R, Corfini M, Giovannitti MG, Di Cianni G, Del Prato S, Miccoli R.

Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):31-8. Epub 2007 Apr 8.

PMID:
17420118
12.

Factors responsible for the evolution of insulin resistance in Japanese type 2 diabetic patients: association with atherosclerosis.

Taniguchi A, Fukushima M, Nakai Y, Kuroe A, Ohya M, Ohgushi M, Seino Y.

Diabetes Res Clin Pract. 2007 Sep;77 Suppl 1:S213-9. Epub 2007 May 25.

PMID:
17532086
13.

Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis.

Nishida M, Moriyama T, Ishii K, Takashima S, Yoshizaki K, Sugita Y, Yamauchi-Takihara K.

Clin Chim Acta. 2007 Sep;384(1-2):99-104. Epub 2007 Jun 16.

PMID:
17618612
14.
15.

Relationship between metabolic syndrome components and vascular properties in Japanese type 2 diabetic patients without cardiovascular disease or nephropathy.

Yokoyama H, Kuramitsu M, Kanno S, Tada J, Yokota Y, Kamikawa F.

Diabetes Res Clin Pract. 2007 Feb;75(2):200-6. Epub 2006 Jul 24.

PMID:
16860430
16.

Five-item version of the international index of erectile function correlated with albuminuria and subclinical atherosclerosis in men with type 2 diabetes.

Fukui M, Tanaka M, Okada H, Iwase H, Mineoka Y, Senmaru T, Ohnishi M, Mogami S, Kitagawa Y, Yamazaki M, Hasegawa G, Nakamura N.

J Atheroscler Thromb. 2011;18(11):991-7. Epub 2011 Jul 26.

17.

The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.

Nam JS, Park JS, Cho MH, Jee SH, Lee HS, Ahn CW, Lowe WL Jr, Kim KR.

Diabetes Res Clin Pract. 2009 May;84(2):145-51. doi: 10.1016/j.diabres.2009.02.002. Epub 2009 Mar 3.

PMID:
19261346
18.

Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population.

Sung SH, Chuang SY, Sheu WH, Lee WJ, Chou P, Chen CH.

Am J Cardiol. 2009 May 15;103(10):1411-6. doi: 10.1016/j.amjcard.2009.01.355. Epub 2009 Apr 1.

PMID:
19427438
19.

Role of endogenous androgen against insulin resistance and athero- sclerosis in men with type 2 diabetes.

Fukui M, Kitagawa Y, Ose H, Hasegawa G, Yoshikawa T, Nakamura N.

Curr Diabetes Rev. 2007 Feb;3(1):25-31. Review.

PMID:
18220653
20.

Serum DHEA-S level is associated with the presence of atherosclerosis in postmenopausal women with type 2 diabetes mellitus.

Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S, Sugimoto T.

Endocr J. 2008 Aug;55(4):667-75. Epub 2008 May 21.

Supplemental Content

Support Center